OrbiMed’s Xenon Pharmaceuticals XENE Stock Holding History

OrbiMed’s Portfolio XENE Stock Details XENE Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$29.7M	Hold	947,877	–	–	0.74%	34
2025 Q1	$31.8M	Hold	947,877	–	–	0.76%	36
2024 Q4	$37.2M	Buy	947,877 +36,457	+4%	+$1.43M	0.76%	38
2024 Q3	$35.9M	Buy	911,420 +49,058	+6%	+$1.93M	0.65%	45
2024 Q2	$33.6M	Buy	862,362 +312,362	+57%	+$12.2M	0.66%	44
2024 Q1	$23.7M	Hold	550,000	–	–	0.43%	59
2023 Q4	$25.3M	Sell	550,000 -408,793	-43%	-$18.8M	0.51%	57
2023 Q3	$32.8M	Sell	958,793 -137,207	-13%	-$4.69M	0.7%	54
2023 Q2	$42.2M	Sell	1,096,000 -53,100	-5%	-$2.04M	0.76%	46
2023 Q1	$41.1M	Hold	1,149,100	–	–	0.81%	42
2022 Q4	$45.3M	Buy	1,149,100 +11,800	+1%	+$465K	0.87%	44
2022 Q3	$41.1K	Sell	1,137,300 -191,900	-14%	-$6.93K	0.76%	49
2022 Q2	$40.4K	Buy	1,329,200 +643,200	+94%	+$19.6K	0.73%	45
2022 Q1	$21M	Buy	686,000 +55,000	+9%	+$1.68M	0.34%	65
2021 Q4	$19.7M	Buy	631,000 +154,000	+32%	+$4.81M	0.25%	85
2021 Q3	$7.29M	Sell	477,000 -857,217	-64%	-$13.1M	0.08%	141
2021 Q2	$24.8M	Sell	1,334,217 -1,163,700	-47%	-$21.7M	0.25%	89
2021 Q1	$44.7M	Hold	2,497,917	–	–	0.42%	67
2020 Q4	$38.4M	Hold	2,497,917	–	–	0.34%	72
2020 Q3	$27.7M	Hold	2,497,917	–	–	0.35%	73
2020 Q2	$31.3M	Buy	2,497,917 +835,105	+50%	+$10.5M	0.44%	63
2020 Q1	$18.9M	Buy	1,662,812 +1,028,000	+162%	+$11.7M	0.32%	69
2019 Q4	$8.32M	Hold	634,812	–	–	0.12%	85
2019 Q3	$5.72M	Hold	634,812	–	–	0.11%	85
2019 Q2	$6.26M	Hold	634,812	–	–	0.1%	97
2019 Q1	$6.45M	Hold	634,812	–	–	0.1%	96
2018 Q4	$4.01M	Hold	634,812	–	–	0.07%	104
2018 Q3	$8.38M	Hold	634,812	–	–	0.1%	115
2018 Q2	$5.84M	Hold	634,812	–	–	0.07%	123
2018 Q1	$3.11M	Hold	634,812	–	–	0.04%	120
2017 Q4	$1.79M	Hold	634,812	–	–	0.02%	120
2017 Q3	$1.87M	Hold	634,812	–	–	0.02%	127
2017 Q2	$2M	Hold	634,812	–	–	0.02%	124
2017 Q1	$2.54M	Sell	634,812 -365,188	-37%	-$1.46M	0.03%	119
2016 Q4	$7.7M	Hold	1,000,000	–	–	0.1%	95
2016 Q3	$8.1M	Buy	+1,000,000	New	+$8.1M	0.09%	106